贵州中毅达股份有限公司2025 年半年度报告 公司代码：600610 、900906 公司简称：中毅达 中毅达 B 贵州中毅达股份有限公司 贵州中毅达股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人申苗、主管会计工作负责人蔡文洁及会计机构负责人（会计主管人员）蔡文洁 声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计划、发展战略等前瞻性陈述不构成公司对投资者的实质承诺，敬请 投资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 公司已在本报告中详细 ...

贵州中毅达股份有限公司 2025 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 贵州中毅达股份有限公司（以下简称"公司"）根据《上海证券交易所上市 公司自律监管指引第 3 号行业信息披露：第十三号——化工》的相关要求，现将 2025 年半年度主要经营数据披露如下： | 股证券代码：600610 | 股证券简称：中毅达 | 公告编号：2025-047 | A | A | | --- | --- | --- | --- | --- | | 股证券代码：900906 | 股证券简称：中毅达 | B | B | B | 主要产品 2025 年 1-6 月产量 （吨） 2025 年 1-6 月销量 （吨） 2025 年 1-6 月营业 收入（万元） 季戊四醇 24,824.86 23,704.29 31,042.50 三羟甲基丙烷 5,530.61 6,554.30 5,493.85 酒精 22,268.88 13,427.09 5,976.35 DDGS 饲料 18,933.85 19,735.55 3,7 ...

Core Viewpoint - The company has issued multiple warnings regarding stock trading risks, indicating that its stock price has significantly deviated from its fundamental value, with a notable increase in trading risk alerts this year [1][2]. Group 1: Stock Performance and Company Fundamentals - From March 10 to June 6, the company's stock price increased by 297%, while its fundamental business conditions remained unchanged, with a price-to-book ratio significantly higher than the industry average [2]. - The company reported a net loss of 14.08 million yuan for the fiscal year 2024, but turned a profit of 1.376 million yuan in the first quarter of 2025, indicating a potential recovery [2]. - The company has a cumulative undistributed profit balance of -2.098 billion yuan as of December 31, 2024, which poses a risk of long-term inability to distribute cash dividends [2]. Group 2: Product and Market Dynamics - The price of the company's main product, dipentaerythritol, has significantly increased, contributing to a substantial rise in gross profit margins and net profit [3]. - The company has a production capacity of 43,000 tons for dipentaerythritol, ranking second in the domestic industry, just behind Hubei Yihua [3]. Group 3: Regulatory and Compliance Issues - The company has faced scrutiny regarding its production capacity exceeding environmental assessment limits, raising concerns about compliance with relevant laws and regulations [4]. - The company has been subject to administrative penalties in the past, including a fine of 20,000 yuan, but claims that it has not faced significant penalties in the last 36 months [5].

Core Viewpoint - The document provides a supplementary legal opinion regarding the stock issuance by Guizhou Zhongyida Co., Ltd. to specific investors, confirming compliance with relevant laws and regulations [1][3][4]. Group 1: Legal Compliance - The issuance scale is not to exceed RMB 210 million, with Tianjin Xinjing as the designated investor [5][9]. - Tianjin Xinjing qualifies as an investor under the relevant regulations, being a controlled entity of the major shareholder [6][9]. - The subscription agreement specifies that Tianjin Xinjing will acquire up to 68,403,908 shares at a price of RMB 3.07 per share [8][9]. Group 2: Production Capacity and Compliance - The company has reported production capacities exceeding environmental assessment limits for several products, including pentaerythritol and food-grade alcohol, with utilization rates above 120% [9][12]. - The company has faced administrative penalties in the past, including a fine of RMB 20,000 for safety violations [10][21]. - Environmental and safety compliance has been confirmed by local authorities, indicating no significant violations or penalties since 2021 [18][19][21].

Core Viewpoint - Zhongyida's stock price has increased by 298.76% since March 10, 2025, despite the company reporting a net loss of 14.08 million yuan for the fiscal year 2024 [1]. Financial Performance - The company reported a net profit of 13.76 million yuan in the first quarter of 2025 [1]. - As of the end of the first quarter of 2025, the company's goodwill was valued at 160 million yuan, while its net asset value was 81.01 million yuan, indicating that the goodwill exceeds the net asset value [2]. - The cumulative undistributed profit balance as of December 31, 2024, was -2.098 billion yuan, which means profits will first be used to cover previous losses before any cash dividends can be distributed [2]. Market Position - Zhongyida's price-to-book ratio is 193.21, significantly higher than the industry average of 1.92 for the chemical raw materials and chemical products manufacturing sector [1]. - The company acknowledges that its stock price is significantly detached from its fundamentals, indicating a potential for market over-exuberance and high speculation risk [1]. Business Operations - The main operating entity of Zhongyida is its wholly-owned subsidiary, Chifeng Ruiyang, which focuses on the production and sales of fine chemical products, including various types of pentaerythritol and feed products [1]. - The company has not reported any significant changes in its fundamental operations and has confirmed that its production activities are normal [2][3]. Goodwill and Risks - In 2023, Zhongyida recorded a goodwill impairment loss of 49.99 million yuan, but no impairment loss was reported for 2024 [2]. - There is a risk of further goodwill impairment if the operational conditions of Chifeng Ruiyang do not improve or if its profitability does not meet expectations [2]. Disclosure and Compliance - The company has confirmed that there are no undisclosed significant events apart from the planned issuance of A-shares disclosed on August 14, 2024 [3].